Enfusion Vs. ePlus Industry Stock Comparison

Buy

64

ENFN
Enfusion

Last Price:

9.85

Seasonality Move:

-16.47%

Sell

29

PLUS
ePlus

Last Price:

80.50

Seasonality Move:

20.86%

Buy

64

Enfusion (ENFN) is a Buy

Is Enfusion a Buy, Sell or Hold?

The current Enfusion [ENFN] share price is $9.88. The Score for ENFN is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
ENFN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Sell

29

ePlus (PLUS) is a Sell

Is ePlus a Buy, Sell or Hold?

The current ePlus [PLUS] share price is $80.48. The Score for PLUS is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
PLUS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ENFN Stock Price Chart

What is Enfusion's stock price today?

The Enfusion share price today is $9.88
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ENFN is experiencing slight selling pressure.

PLUS Stock Price Chart

What is ePlus's stock price today?

The ePlus share price today is $80.48
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PLUS is experiencing slight selling pressure.

ENFN Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.2	Buy
Relative Strength Index (14 RSI):	67.83	Buy
Chaikin Money Flow:	-66167	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	( - )	Buy
Bollinger Bands (100):	( - )	Buy

PLUS Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-2.29	Sell
Relative Strength Index (14 RSI):	29.13	Sell
Chaikin Money Flow:	-131262	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(89.57 - 100.91)	Sell
Bollinger Bands (100):	(81.36 - 98.26)	Sell

ENFN Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	9.45	Buy
20-day SMA:	9.16	Buy
50-day SMA:	8.95	Buy
200-day SMA:	8.9	Buy
8-day EMA:	9.5	Buy
20-day EMA:	9.26	Buy
50-day EMA:	9.02	Buy
200-day EMA:	8.97	Buy

PLUS Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	92.25	Sell
20-day SMA:	94.05	Sell
50-day SMA:	95.08	Sell
200-day SMA:	83.6	Sell
8-day EMA:	89.64	Sell
20-day EMA:	92.96	Sell
50-day EMA:	93.52	Sell
200-day EMA:	84.4	Sell

Enfusion Earnings Growth & ENFN Earnings Dates

Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.07 per share, and an increase next year of $0.08 per share.

ePlus Earnings Growth & PLUS Earnings Dates

Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.53 per share, and a decrease next year of $0.07 per share.

Enfusion Technical Analysis

	Nov 1	Nov 4	Nov 5	Nov 6	Nov 7	Nov 8	Nov 11	Nov 12	Nov 13	Nov 14
	Nov
	01	04	05	06	07	08	11	12	13	14
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

ePlus Technical Analysis

	Nov 1	Nov 4	Nov 5	Nov 6	Nov 7	Nov 8	Nov 11	Nov 12	Nov 13	Nov 14
	Nov
	01	04	05	06	07	08	11	12	13	14
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):